Component portfolio and prices
This provides details of therapeutic blood components supplied to hospitals, including constituents, and information on:
- identification barcodes
- quality standards and monitoring
- storage and handling
- clinical indications and contraindications
- specialist requirements
- dosage, administration, recognition of adverse effects
- material safety data sheet
Availability of non stock and special components
Availability of non stock and special components including components required for urgent requests.
SaBTO’s recommendations on vCJD risk reduction measures
NHSBT communication issued 9 September 2019 regarding the Department for Health and Social Care's (DHSC) notification of the ministerial decision to accept SaBTO’s recommendations on vCJD risk reduction measures in England, Wales and Scotland for plasma and platelet recipients born on or after 1 January 1996.